The Trump administration continues to spar with the pharmaceutical industry. The latest jab is the reemergence of the discussion on drug importation. U.S. Department of Health & Human Services (HHS) Secretary Alex Azar reversed the administration’s course on whether drugs could be purchased outside of the United States and reimported. The reality is that drugs… [Read More]